Clinical Trial Update: Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel and cetuximab in metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED